Qiagen (QGEN) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
QIAGEN Reports Results for Fourth Quarter and Full-Year 2019
February 4, 2020 4:05 PM ESTDelivers on Q4 2019 net sales outlook, exceeds on adjusted EPS Net sales of $413.5 million (+3% actual, +4% CER, vs. ~+3% CER outlook) Diluted EPS $0.19; adjusted EPS $0.48 ($0.48 CER, +20% CER vs. ~$0.45-0.46 CER outlook) Adjusted operating income margin rises to 33.5% of sales vs. 29.6% in Q4 2018 Achieves FY 2019 net sales outlook, exceeds on adjusted EPS Net sales of $1.53 billion (+2% actual, +4% CER, vs. ~+4% CER outlook) Net loss per share $0.18; adjusted EPS $1.43 ($1.46 CER, +9% CER vs. ~$1.43-1.44 CER outlook) Adjusted operating income... More



